Delivery Order SPE2DB20D9214-SPE2DB25FD4WU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with an ultimate completion date of July 9, 2025. The award was made without a set-aside designation, allowing the vendor to compete directly in the federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract, awarded on August 19, 2025, with an ultimate completion date of September 10, 2025, operates under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 30, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the vendor to compete on an open basis despite its small...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The contract carries a firm fixed-price structure with an ultimate completion date of June 23, 2025, and no set-aside designation was used in the award. This delivery...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a single transaction under the company's larger Indefinite Delivery Contract with DLA, valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, IL. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, was awarded without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/mL syringes valued at $16,249.95. The award was issued on June 24, 2025, with an ultimate completion date of July 16, 2025, under a firm fixed-price delivery order contract with no set-aside designation. This delivery order represents a single procurement action under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $32,499.90 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, is set to be completed by October 9, 2025, and will be performed at the contractor's Park Ridge facility. The award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB20D9214Indefinite Delivery Contract
- SPE2DB20D9214-SPE2DB25FD4WUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/mL syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its facility in Park Ridge, IL. The delivery order operates under a firm fixed-price structure with an ultimate completion date of August 27, 2025, and was issued without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities nationwide. Stelara is a biologic medication commonly used to treat autoimmune conditions, and this procurement reflects the Defense Logistics Agency's ongoing need to maintain pharmaceutical inventory for military health services. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, with an extensive portfolio of contract awards covering branded and generic prescription drugs, biologics, vaccines, and specialty medications. The company's consistent success in securing delivery orders without specific set-aside designations demonstrates its competitive position in federal procurement markets while leveraging its woman-owned small business status.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/6/25 |